Institute of Pathology
Alessandro Lugli has not added Biography.
If you are Alessandro Lugli and would like to personalize this page please email our Author Liaison for assistance.
High-throughput tissue microarray analysis of G1-cyclin alterations in classical Hodgkin's lymphoma indicates overexpression of cyclin E1.
The Journal of pathology Feb, 2003 | Pubmed ID: 12533833
Calretinin expression in human normal and neoplastic tissues: a tissue microarray analysis on 5233 tissue samples.
Human pathology Oct, 2003 | Pubmed ID: 14608532
Expression of B-cell markers in classical hodgkin lymphoma: a tissue microarray analysis of 330 cases.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc Nov, 2003 | Pubmed ID: 14614054
Macrofollicular variant of papillary carcinoma of the thyroid: a histologic, cytologic, and immunohistochemical study of 3 cases and review of the literature.
Archives of pathology & laboratory medicine Jan, 2004 | Pubmed ID: 14692811
Frequent EpCam protein expression in human carcinomas.
Human pathology Jan, 2004 | Pubmed ID: 14745734
Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancer.
Nature genetics Sep, 2004 | Pubmed ID: 15300251
Hepatocyte paraffin 1 expression in human normal and neoplastic tissues: tissue microarray analysis on 3,940 tissue samples.
American journal of clinical pathology Nov, 2004 | Pubmed ID: 15491968
Prevalence of KIT expression in human tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Nov, 2004 | Pubmed ID: 15542802
Proposal of a morphologic bone marrow response score for imatinib mesylate treatment in chronic myelogenous leukemia.
Human pathology Jan, 2005 | Pubmed ID: 15712187
Patterns of gene amplification in gastrointestinal stromal tumors (GIST).
Laboratory investigation; a journal of technical methods and pathology Jul, 2005 | Pubmed ID: 15864317
EphB2 expression across 138 human tumor types in a tissue microarray: high levels of expression in gastrointestinal cancers.
Clinical cancer research : an official journal of the American Association for Cancer Research Sep, 2005 | Pubmed ID: 16166419
Construction and validation of a bone marrow tissue microarray.
Journal of clinical pathology Jan, 2007 | Pubmed ID: 16698953
Scoring of p53, VEGF, Bcl-2 and APAF-1 immunohistochemistry and interobserver reliability in colorectal cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc Sep, 2006 | Pubmed ID: 16741523
Overexpression of the receptor for hyaluronic acid mediated motility is an independent adverse prognostic factor in colorectal cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc Oct, 2006 | Pubmed ID: 16763611
Role of the mitogen-activated protein kinase and phosphoinositide 3-kinase/AKT pathways downstream molecules, phosphorylated extracellular signal-regulated kinase, and phosphorylated AKT in colorectal cancer-a tissue microarray-based approach.
Human pathology Aug, 2006 | Pubmed ID: 16867865
Prognostic value of cell cycle and apoptosis regulatory proteins in mismatch repair-proficient colorectal cancer: a tissue microarray-based approach.
American journal of clinical pathology Jan, 2007 | Pubmed ID: 17145638
Selecting immunohistochemical cut-off scores for novel biomarkers of progression and survival in colorectal cancer.
Journal of clinical pathology Oct, 2007 | Pubmed ID: 17182662
Napoleon Bonaparte's gastric cancer: a clinicopathologic approach to staging, pathogenesis, and etiology.
Nature clinical practice. Gastroenterology & hepatology Jan, 2007 | Pubmed ID: 17203089
Differential significance of tumour infiltrating lymphocytes in sporadic mismatch repair deficient versus proficient colorectal cancers: a potential role for dysregulation of the transforming growth factor-beta pathway.
European journal of cancer (Oxford, England : 1990) Feb, 2007 | Pubmed ID: 17223543
Prognostic significance of mammalian sterile20-like kinase 1 in colorectal cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc Mar, 2007 | Pubmed ID: 17277767
Loss of APAF-1 expression is associated with tumour progression and adverse prognosis in colorectal cancer.
European journal of cancer (Oxford, England : 1990) Apr, 2007 | Pubmed ID: 17350821
Close association between HER-2 amplification and overexpression in human tumors of non-breast origin.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc Feb, 2007 | Pubmed ID: 17361205
Loss of raf-1 kinase inhibitor protein expression is associated with tumor progression and metastasis in colorectal cancer.
American journal of clinical pathology May, 2007 | Pubmed ID: 17439843
Value of staining intensity in the interpretation of immunohistochemistry for tumor markers in colorectal cancer.
Virchows Archiv : an international journal of pathology Oct, 2007 | Pubmed ID: 17674041
Multimarker phenotype predicts adverse survival in patients with lymph node-negative colorectal cancer.
Cancer Feb, 2008 | Pubmed ID: 18076013
Node-negative colorectal cancer at high risk of distant metastasis identified by combined analysis of lymph node status, vascular invasion, and Raf-1 kinase inhibitor protein expression.
Clinical cancer research : an official journal of the American Association for Cancer Research Jan, 2008 | Pubmed ID: 18172264
Chromosomal instability in gastric mucosa-associated lymphoid tissue lymphomas: a fluorescent in situ hybridization study using a tissue microarray approach.
Human pathology Apr, 2008 | Pubmed ID: 18234275
Local recurrence in mismatch repair-proficient colon cancer predicted by an infiltrative tumor border and lack of CD8+ tumor-infiltrating lymphocytes.
Clinical cancer research : an official journal of the American Association for Cancer Research Jun, 2008 | Pubmed ID: 18559598
RHAMM, p21 combined phenotype identifies microsatellite instability-high colorectal cancers with a highly adverse prognosis.
Clinical cancer research : an official journal of the American Association for Cancer Research Jun, 2008 | Pubmed ID: 18559599
Differential diagnostic and functional role of the multi-marker phenotype CDX2/CK20/CK7 in colorectal cancer stratified by mismatch repair status.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc Nov, 2008 | Pubmed ID: 18587323
Is immunohistochemical epidermal growth factor receptor expression overestimated as a prognostic factor in head-neck squamous cell carcinoma? A retrospective analysis based on a tissue microarray of 365 carcinomas.
Human pathology Oct, 2008 | Pubmed ID: 18620726
Tumor border configuration added to TNM staging better stratifies stage II colorectal cancer patients into prognostic subgroups.
Cancer Sep, 2009 | Pubmed ID: 19517467
Combined histomorphologic and immunohistochemical phenotype to predict the presence of vascular invasion in colon cancer.
Diseases of the colon and rectum Jun, 2009 | Pubmed ID: 19581855
Is the improved prognosis of p16 positive oropharyngeal squamous cell carcinoma dependent of the treatment modality?
International journal of cancer. Journal international du cancer Mar, 2010 | Pubmed ID: 19697324
Urokinase-type plasminogen activator is a marker of aggressive phenotype and an independent prognostic factor in mismatch repair-proficient colorectal cancer.
Human pathology Jan, 2010 | Pubmed ID: 19740518
High frequency of tumor-infiltrating FOXP3(+) regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients.
International journal of cancer. Journal international du cancer Jun, 2010 | Pubmed ID: 19856313
Clinicopathological and protein characterization of BRAF- and K-RAS-mutated colorectal cancer and implications for prognosis.
International journal of cancer. Journal international du cancer Jul, 2010 | Pubmed ID: 19908233
Systematic assessment of the prognostic impact of membranous CD44v6 protein expression in colorectal cancer.
Histopathology Nov, 2009 | Pubmed ID: 19912362
Invasive front of colorectal cancer: dynamic interface of pro-/anti-tumor factors.
World journal of gastroenterology : WJG Dec, 2009 | Pubmed ID: 20014453
ABCG5-positivity in tumor buds is an indicator of poor prognosis in node-negative colorectal cancer patients.
World journal of gastroenterology : WJG Feb, 2010 | Pubmed ID: 20135722
Combined analysis of specific KRAS mutation, BRAF and microsatellite instability identifies prognostic subgroups of sporadic and hereditary colorectal cancer.
International journal of cancer. Journal international du cancer Dec, 2010 | Pubmed ID: 20162668
Role of the VEGF ligand to receptor ratio in the progression of mismatch repair-proficient colorectal cancer.
BMC cancer , 2010 | Pubmed ID: 20222950
Archaeology dig into the duodenal biopsy.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver Jul, 2010 | Pubmed ID: 20471923
The loss of the CBX7 gene expression represents an adverse prognostic marker for survival of colon carcinoma patients.
European journal of cancer (Oxford, England : 1990) Aug, 2010 | Pubmed ID: 20542683
Role of tumor size in the pre-operative management of rectal cancer patients.
BMC gastroenterology , 2010 | Pubmed ID: 20550703
Expression of p16 in lymph node metastases of adjuvantly treated stage III colorectal cancer patients identifies poor prognostic subgroups: a retrospective analysis of biomarkers in matched primary tumor and lymph node metastases.
Cancer Oct, 2010 | Pubmed ID: 20572035
Tumor infiltration by FcγRIII (CD16)+ myeloid cells is associated with improved survival in patients with colorectal carcinoma.
International journal of cancer. Journal international du cancer Jun, 2011 | Pubmed ID: 20715106
Systematic assessment of protein phenotypes characterizing high-grade tumour budding in mismatch repair-proficient colorectal cancer.
Histopathology Aug, 2010 | Pubmed ID: 20716165
Co-overexpression of p21 and Ki-67 in head and neck squamous cell carcinoma relative to a significantly poor prognosis.
Head & neck Feb, 2011 | Pubmed ID: 20848449
Tumor budding predicts response to anti-EGFR therapies in metastatic colorectal cancer patients.
World journal of gastroenterology : WJG Oct, 2010 | Pubmed ID: 20939111
TIA-1 cytotoxic granule-associated RNA binding protein improves the prognostic performance of CD8 in mismatch repair-proficient colorectal cancer.
PloS one , 2010 | Pubmed ID: 21179245
Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget.
Oncotarget Nov, 2010 | Pubmed ID: 21317460
The medical mystery of Napoleon Bonaparte: an interdisciplinary exposé.
Advances in anatomic pathology Mar, 2011 | Pubmed ID: 21326012
Comprehensive analysis of CpG island methylator phenotype (CIMP)-high, -low, and -negative colorectal cancers based on protein marker expression and molecular features.
The Journal of pathology Nov, 2011 | Pubmed ID: 21660972
Systematic analysis of proteins from different signaling pathways in the tumor center and the invasive front of colorectal cancer.
Human pathology Dec, 2011 | Pubmed ID: 21664646
Intratumoral budding as a potential parameter of tumor progression in mismatch repair-proficient and mismatch repair-deficient colorectal cancer patients.
Human pathology Dec, 2011 | Pubmed ID: 21664647
VEGFA gene locus (6p12) amplification identifies a small but highly aggressive subgroup of colorectal cancer [corrected] patients.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc Oct, 2011 | Pubmed ID: 21743435
Characterization of the immunological microenvironment of tumour buds and its impact on prognosis in mismatch repair-proficient and -deficient colorectal cancers.
Histopathology Sep, 2011 | Pubmed ID: 22034888
Standardization of whole slide image morphologic assessment with definition of a new application: Digital slide dynamic morphometry.
Journal of pathology informatics , 2011 | Pubmed ID: 22200031
Intra-tumoral budding in preoperative biopsy specimens predicts lymph node and distant metastasis in patients with colorectal cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc Jul, 2012 | Pubmed ID: 22481282
Stratification and Prognostic Relevance of Jass's Molecular Classification of Colorectal Cancer.
Frontiers in oncology , 2012 | Pubmed ID: 22655257
Metastases and primary tumors around dental implants: A literature review and case report of peri-implant pulmonary metastasis.
Quintessence international (Berlin, Germany : 1985) Jul-Aug, 2012 | Pubmed ID: 22670251
Diagnostic reproducibility of tumour budding in colorectal cancer: a multicentre, multinational study using virtual microscopy.
Histopathology Jul, 2012 | Pubmed ID: 22765314
The impact of CpG island methylator phenotype and microsatellite instability on tumour budding in colorectal cancer.
Histopathology Nov, 2012 | Pubmed ID: 22803799
Role of intra- and peritumoral budding in the interdisciplinary management of rectal cancer patients.
International journal of surgical oncology , 2012 | Pubmed ID: 22900161
Characterization of CDKN2A(p16) methylation and impact in colorectal cancer: systematic analysis using pyrosequencing.
Journal of translational medicine , 2012 | Pubmed ID: 22925370
Proposal for a 10-high-power-fields scoring method for the assessment of tumor budding in colorectal cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc Feb, 2013 | Pubmed ID: 23018875
Cancer classification using the Immunoscore: a worldwide task force.
Journal of translational medicine , 2012 | Pubmed ID: 23034130
Tumor budding score based on 10 high-power fields is a promising basis for a standardized prognostic scoring system in stage II colorectal cancer.
Human pathology May, 2013 | Pubmed ID: 23159156
The additional facet of immunoscore: immunoprofiling as a possible predictive tool for cancer treatment.
Journal of translational medicine , 2013 | Pubmed ID: 23452415
Clinical impact of programmed cell death ligand 1 expression in colorectal cancer.
European journal of cancer (Oxford, England : 1990) Jun, 2013 | Pubmed ID: 23478000
Next-generation tissue microarray (ngTMA) increases the quality of biomarker studies: an example using CD3, CD8, and CD45RO in the tumor microenvironment of six different solid tumor types.
Journal of translational medicine , 2013 | Pubmed ID: 23627766
High myeloperoxidase positive cell infiltration in colorectal cancer is an independent favorable prognostic factor.
PloS one , 2013 | Pubmed ID: 23734221
The apoptotic and proliferation rate of tumour budding cells in colorectal cancer outlines a heterogeneous population of cells with various impacts on clinical outcome.
Histopathology Mar, 2014 | Pubmed ID: 24111856
Towards the introduction of the 'Immunoscore' in the classification of malignant tumours.
The Journal of pathology Jan, 2014 | Pubmed ID: 24122236
Loss of Cdx2 Expression in Primary Tumors and Lymph Node Metastases is Specific for Mismatch Repair-Deficiency in Colorectal Cancer.
Frontiers in oncology , 2013 | Pubmed ID: 24130965
Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high-level CpG Island methylator phenotype and mismatch repair-deficiency.
International journal of cancer. Journal international du cancer May, 2014 | Pubmed ID: 24166180
Loss of Raf-1 kinase inhibitor protein (RKIP) is strongly associated with high-grade tumor budding and correlates with an aggressive phenotype in pancreatic ductal adenocarcinoma (PDAC).
Journal of translational medicine , 2013 | Pubmed ID: 24330423
HLA class II antigen expression in colorectal carcinoma tumors as a favorable prognostic marker.
Neoplasia (New York, N.Y.) Jan, 2014 | Pubmed ID: 24563618
The tumor border configuration of colorectal cancer as a histomorphological prognostic indicator.
Frontiers in oncology , 2014 | Pubmed ID: 24600585
CD8/CD45RO T-cell infiltration in endoscopic biopsies of colorectal cancer predicts nodal metastasis and survival.
Journal of translational medicine , 2014 | Pubmed ID: 24679169
Defined morphological criteria allow reliable diagnosis of colorectal serrated polyps and predict polyp genetics.
Virchows Archiv : an international journal of pathology Jun, 2014 | Pubmed ID: 24728704
Investigation of IL-23 (p19, p40) and IL-23R identifies nuclear expression of IL-23 p19 as a favorable prognostic factor in colorectal cancer: a retrospective multicenter study of 675 patients.
Oncotarget Jul, 2014 | Pubmed ID: 25015728
Evaluation of colon cancer histomorphology: a comparison between formalin and PAXgene tissue fixation by an international ring trial.
Virchows Archiv : an international journal of pathology Aug, 2014 | Pubmed ID: 25085759
Tumor budding in upper gastrointestinal carcinomas.
Frontiers in oncology , 2014 | Pubmed ID: 25177546
ACERCA DE JoVE
Copyright © 2024 MyJoVE Corporation. Todos los derechos reservados